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Introduction
A major feature of the cystic fibrosis (CF) airways is the presence of free and active proteases, which are responsible for the destruction of lung tissue and other soluble proteins present in the respiratory tract. In CF, disruption of the protease-antiprotease balance has been demonstrated to be established by the age of 1 yr, and is thought to be sustained chronically thereafter (1) . Lung remodelling is evident soon after diagnosis even in children diagnosed with CF following newborn screening (2) (3) (4) (5) . Furthermore, structural lung disease is progressive and is associated with worsening inflammation and pulmonary infection (6, 7) . Neutrophil elastase (NE) is regarded as a key driver of lung destruction (3, 8) and inflammation especially during chronic Pseudomonas aeruginosa infection (9, 10) . In contrast to NE, the role of cysteine cathepsins in CF has been relatively unexplored to date.
In the last decade, attention to the role of cathepsin S (CTSS) in diseases such as cancer and heart disease has greatly increased (11, 12). We and others have previously reported the presence of members of the elastolytic cathepsin family including CTSS in cell-free CF lung secretions (13) (14) (15) (16) . In contrast to other cysteine cathepsin isoforms, CTSS can retain proteolytic activity after prolonged exposure to neutral pH in the extracellular environment, where it retains nearly as much elastase activity as NE (17) (18) (19) (20) . Consequently, in addition to pivotal roles in cellular events such as antigen processing (21), CTSS has the capacity to promote remodelling of the extracellular matrix via its potent elastinolytic activity. A recent report demonstrated the ability of CTSS to activate ENaC, which may be pathophysiologically relevant in inflammatory diseases such as CF (22) . In addition, CTSS can cleave and inactivate key antimicrobials in the CF 4 airways including surfactant protein A (23) , lactoferrin (14) and members of the β-defensin family (13) . In contrast to NE, the cellular sources and role of CTSS in the CF lung has been relatively unexplored to date.
In this study, we expand our previous investigations into the presence and activity of CTSS in the CF lung with a focus on young CF patients. A range of epithelial dysfunctions have been implicated in the pathogenesis of CF lung disease which are ultimately consequences of mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Given that epithelial cells have been reported to express CTSS (21, 24, 25), we investigated the hypothesis that CF airway epithelial cells contribute to the protease burden of the CF lung by releasing increased levels of CTSS compared to non-CF controls, and explore the mechanism responsible for our observations. Some of the results of these studies have been previously reported in the form of abstracts (26, 27) .
Methods
Full details are available in the online data supplement.
Bronchoalveolar lavage fluid samples and study approval
Group 1 Paediatric CF subjects BAL fluid samples were obtained from 26 patients (0.7 -18 yr, mean age 10.84 yr) diagnosed with CF; 11 with P. aeruginosa infection (Ps+) and 15 without (Ps-), as described previously (9) .
We refer readers to (9) and Table E1 in the online data supplement for further clinical   5 information, cell counts and details of pathogens detected in this cohort of patients. Ethical approval was obtained from the institutional review board of the Adelaide and Meath Hospital incorporating the National Children's Hospital with all parents providing written informed consent prior to participation.
Group 2 Pre-school CF and non-CF subjects
BAL fluid was obtained from Pseudomonas negative children with CF (n = 43; 0.9 -5 yr, mean age 2.91 yr) through the SHIELD (Study of Host Immunity and Early Lung Disease in CF) CF study.
In addition, 9 children who did not have CF (0.9 -3 yr, mean age 1.73 yr) were included as a non-CF control group. Children in this control group were undergoing clinically indicated BAL for a variety of reasons, most commonly a history of recurrent respiratory infection, haemoptysis or cough. Details of pathogens detected and cell counts in the CF and non-CF BAL fluid and CF genotype details are presented in Table E2 in the online supplement. Ethical approval was obtained from the institutional review board of Our Lady's Children's Hospital Crumlin with all parents providing written informed consent prior to participation.
Primary bronchial epithelial cell culture and study approval
Primary cultures of well-differentiated human bronchial epithelial cells (PBECs) were obtained from patients with CF (n = 8) and from non-CF (n = 8) healthy volunteers and grown at the airliquid interface (28) . The use of human tissues was approved by the University of Iowa Institutional Review Board. 6 
Bronchial brush analysis and study approval
Following informed consent under a protocol approved by Beaumont Hospital Institutional Review Board, bronchial brushings were sampled from patients with CF (n = 5) and non-CF (n = 5) volunteers.
Epithelial cell lines
The human bronchial epithelial cell line 16HBE14o-(HBE), the CF bronchial epithelial cell line penicillin/streptomycin (PAA Laboratories GmbH, Austria) at 37°C under 5% CO2.
Statistical analysis
All data were analysed using GraphPad Prism 5.0 (GraphPad Software Inc., San Diego, CA) and are reported as mean ± SEM or median (IQR) where appropriate. Results are representative of at least n = 3 unless otherwise indicated. Means were compared by unpaired t-test, Mann Whitney test, one-way analysis of variance (ANOVA) or Kruskal-Wallis test as appropriate. P < 0.05 was accepted to indicate statistical significance. The relationships between clinical parameters were verified using Spearman correlation. 
Results
Increased CTSS in the CF lung correlates negatively with lung function in a paediatric CF patient cohort
We previously reported the presence of active CTSS in the CF lung (13, 14) . In this study, we expanded these observations by first comparing CTSS activity and levels in BAL fluid from a cohort of paediatric CF patients stratified on the basis of the absence (Ps-; n = 15) or presence (Ps+; n = 11) of chronic P. aeruginosa infection as described previously (9) . Details of pathogens detected in this CF cohort are presented in Table E1 in the online supplement. In agreement with previous work (16) , there was no significant difference in either CTSS activity or CTSS levels in Ps+ compared with Ps-CF BAL, which supports the suggestion that CTSS may not be not a reliable marker of P. aeruginosa infection in CF. However, both CTSS activity ( Figure 1C ; r = -0.56; P = 0.0069) and CTSS levels ( Figure 1D ; r = -0.58; P = 0.0048) correlated negatively with FEV 1 (% predicted) suggesting that increased CTSS is associated with a decline in lung function in CF. In addition, CF BAL fluid CTSS activity was found to correlate significantly with BAL neutrophil counts ( Figure 1E ; r = 0.6875; P = 0.0001) but not with macrophage counts ( Figure   1F ; r = 0.2759; P = 0.1725).
CTSS is readily detectable in BAL fluid from pre-school CF patients
Our recent findings demonstrate that in CF lung secretions, the level of active NE is significantly increased in Ps+ compared to Ps-CF BAL fluid and sputum (9, 10) . In contrast, CTSS activity and levels were found to be significantly elevated in CF BAL fluid regardless of the status of chronic 8 Pseudomonas infection ( Figure 1A -B). Therefore, in order to extend our analysis of CTSS and NE activities in young CF patients without chronic P. aeruginosa infection, BAL fluid samples were obtained from a cohort of pre-school children with CF (n = 43) who tested negative for P. aeruginosa infection. In addition, BAL fluid was obtained from Pseudomonas negative non-CF children (n = 9). Details of pathogens detected in this cohort of CF and non-CF patients are presented in Table E2 in the online supplement. As illustrated in Figure 2A , the levels of CTSS activity were significantly increased in CF BAL compared to BAL samples from children without CF (P < 0.05). In contrast, no significant difference in NE activity ( Figure 2B ) was detectable between the non-CF and CF BAL samples (P = 0.562). Interestingly, while CTSS activity as detectable in all CF and non-CF BAL samples, NE activity was undetectable in the majority of samples from both groups (66.7% non-CF; 60.5% CF). This level of detection of NE is in agreement with previous reports in the literature (3, 7, 31) . In agreement with our findings above, CF BAL fluid CTSS activity was found to correlate significantly with BAL neutrophil counts ( Figure 2C ; r = 0.4806; P = 0.0015) but not with macrophages ( Figure 2D ; r = 0.2522; P = 0.1165).
Expression and secretion of CTSS from unstimulated CF and non-CF epithelial cells
Evidence to date suggests that CTSS has a restricted tissue distribution with predominant expression in antigen presenting cells; however, more recent work has demonstrated expression of CTSS in airway epithelial cells (24, 25, 32) . Given the prevalence of CTSS in the lungs of children with CF, we investigated whether pulmonary epithelial cells represent a possible source of CTSS in the CF lung. As illustrated in Figure 3 , unstimulated CF tracheal ( Figure 3A ) and bronchial ( Figure 3B ) epithelial cell lines secreted significantly elevated levels of 9 active CTSS compared to non-CF cells. These findings were consistent in well-differentiated primary human bronchial epithelial cells (PBECs) as increased levels of extracellular CTSS activity were detected in both CF apical washes and basolateral media compared to non-CF ( Figure 3C-D) . These findings were consistent with findings by ELISA ( Figure 3E -H) and Western blotting (Supplemental Figure E1) demonstrating that CF airway epithelial cells secrete more CTSS compared to non-CF controls. We next examined the levels of CTSS mRNA in these cells by RT-PCR. In concurrence with the protein data, CTSS expression was found to be elevated in CF tracheal and bronchial epithelial cell lines (CFTE, CFBE) compared to non-CF controls (HTE, HBE; Figure 4A ). These findings were confirmed in PBECs, with significantly increased CTSS mRNA levels detectable in CF PBECs compared to non-CF ( Figure 4B-C) . In contrast to CTSS, no changes in cathepsin B (CTSB) expression were found between CF and non-CF epithelial cells (Supplemental Figure E2 ).
Increased levels of IRF-1 as a result of miR-31 deregulation result in increased expression and secretion of CTSS by CF epithelial cells
A number of transcription factors are reported to regulate the expression of CTSS. Of particular interest is IRF-1, which has been shown to regulate CTSS expression in airway epithelial cells (25) . Therefore, we investigated the status of IRF-1 in whole cell lysates of CF and non-CF cells by Western blotting. Levels of IRF-1 were found to be elevated in CF compared to non-CF epithelial cell lines and consistent between tracheal and bronchial cell types ( Figure 5A ).
Furthermore, levels of IRF-1 were significantly increased in CF PBECs compared to non-CF ( Figure 5B-C). In order to establish a functional relationship between IRF-1 and CTSS in CF epithelial cells, we used short interfering RNA (siRNA) to knock down IRF-1 levels in CFBEs and examined the effects on CTSS levels. As illustrated in Figure 6A , transfection of CFBEs with IRF-1 siRNA effectively decreased IRF-1 protein levels compared to mock transfected (Con) and the scrambled control (Scr). This decrease in IRF-1 protein was associated with a marked reduction in CTSS expression ( Figure 6B ) but not CTSB (Supplemental Figure E3) . Consistent with the reduced expression of CTSS, both extracellular CTSS activity ( Figure 6C ) and levels ( Figure 6D) were significantly decreased in CFBEs transfected with IRF-1 siRNA compared to Scr controls, demonstrating the functional importance of IRF-1 in CFBE CTSS expression. Similarly, a consistent decrease in miR-31 expression was observed in CF PBECs (n = 4; Figure 7B ) and both tracheal ( Figure 7C ) and bronchial ( Figure 7D 
Discussion
In this report, our findings show that CTSS is a highly abundant protease found in the CF lung, even in young children with CF in the absence of chronic Pseudomonas infection. We have demonstrated that CF pulmonary epithelial cells may contribute to the protease burden of the CF lung by expressing and releasing increased levels of active CTSS. Although we have described epithelial cells as a potential source of CTSS in the CF airway, other cell types such as neutrophils and macrophages may also contribute to the CTSS levels found in CF BAL fluid. In this study, we found that CF BAL fluid CTSS activity correlated significantly with BAL neutrophil counts, but not macrophage counts. However, further work is required to delineate the contribution of various cell types to pulmonary CTSS load. In addition, the significant correlation observed also supports the hypothesis that proteases such as CTSS may also play a role in neutrophil recruitment as proposed previously (35) . 12 Further investigation identified miR-31 as a potentially important regulator of CTSS expression via the transcription factor IRF-1 in CF epithelial cells. MiRNAs are short non-coding RNAs that modulate target gene expression via translational repression or degradation of their target RNAs (36) . MiRNAs may regulate up to one-third of all protein coding genes in human genome (37) and it is believed that dysregulation of miRNAs can contribute to disease pathology (38) . Recent work has identified unique miRNA profiles in the CF lung and analysis of target genes has revealed important roles for miRNAs in the regulation of CFTR expression and function and inflammation (34, 39, 40) . MiR-31 is one of the most highly expressed miRNAs present in human non-CF airway epithelial cells (33) and our data demonstrate that miR-31 expression was significantly decreased in CF airway epithelial cell lines and primary cells. Similar to other human genes, miRNA expression can be altered by several mechanisms, such as chromosomal abnormalities, mutations, defects in their biogenesis machinery, epigenetic silencing (DNA methylation, histone modification), or by transcription factors. Work to date suggests that miR-31 expression is regulated by a number of distinct signalling networks in an intricate lineage-and cell type-dependent manner (41) . MiR-31 expression levels can be enhanced by TNF, bone morphogenetic protein-2 and TGF-β1 and by the transcription factor C/EBP-β (42, (45) (46) (47) . Other work has found that miR-31 is subject to epigenetic and nonepigenetic silencing in different human breast cancer cell lines (41, 48) . In addition, reduced mature miR-31 levels may arise due to the defective post-transcriptional processing of the miR- 13 31 RNA precursor rather than transcriptional repression of the miR-31 gene itself (49) . Further work is required to elucidate the cause of decreased miR-31 in the CF lung and how this relates to CFTR dysfunction.
Altered miR-31 expression has been reported in diseases such as cancer and psoriasis, and a number of target genes have been identified including RhoA, PP2A regulatory subunit B alpha isoform and serine/threonine kinase 40 (41, 42, 50) . In this study, we implicate the Neutrophil-dominated inflammation has been shown to play a major role in the pathogenesis of CF lung disease. Work to date has highlighted an association between NE and bronchiectasis (3) and disease severity (8) in young children with CF. Although we found that CTSS was active in a greater number of BAL fluid samples compared to NE, our NE findings correlate closely with those of Sly and colleagues who demonstrated that approximately 18-41% of CF BAL fluid samples from similar age groups contained active NE (3, 31) . Our recent findings demonstrate that in CF lung secretions, the level of active NE is significantly increased in patients with chronic Pseudomonas infection compared to Pseudomonas negative CF patients (9, 10) . These findings are in contrast to the profile of CTSS observed in these patients where BAL fluid CTSS was found to be significantly elevated regardless of the status of chronic 14 Pseudomonas infection compared to healthy control BAL fluid. The findings from this crosssectional investigation also demonstrate the presence of active CTSS in BAL fluid from young CF patients and raise the important question of the potential role of CTSS in CF lung disease.
Previous work indicates that CTSS may also play a role in the diminution of the lung's antimicrobial defences thereby favouring conditions for bacterial infection (13, 14, 23) .
Furthermore, given its potent elastinolytic activity (17) (18) (19) (20) 53) , it is possible that CTSS may play a role in tissue damage and remodelling present in early CF (2, 3, 6, 7) , an increasingly recognized clinical finding over the last 5 years. In addition, the presence of elevated CTSS in the CF airways may explain, in part, why previous therapeutic approaches to protease neutralisation in the CF lung, which have not taken elevated CTSS activity into account, have not been entirely successful to date. At present, there is no available therapy to prevent, limit or reverse airway remodelling. Further work, including longitudinal analysis of CF patients, will be essential to elucidate the role of CTSS in the pathogenesis and progression of CF lung disease.
In conclusion, these novel data not only identify pulmonary epithelial cells as a source of CTSS in the CF lung, but also highlight a mechanism for the increased CTSS via dysregulated miRNA expression, which may represent a link between epithelial CFTR dysfunction and CF lung (A) CTSS and (B) NE activity were quantified in BAL fluid from a cohort of pre-school, Pseudomonas negative non-CF (n = 9) and CF children (n = 43; Group 2). CTSS and NE activities were detected using the fluorogenic substrates FR-AMC (pH 7.5) and AAPV-AMC, respectively.
Results were expressed as the change () in relative fluorescence units (RFU) over time. CTSS activity was detectable in all 43 CF samples analysed, however, in contrast, NE activity was undetectable in the majority of samples (>60%). The correlation between CF BAL fluid CTSS activity and (C) neutrophils and (D) macrophages were determined using Spearman correlation. * = P < 0.05. 
